Health Secretary Robert F. Kennedy Jr. has toned down his public criticism of vaccines, under orders from the White House.

In a large study of 429,595 adults aged 65 years or older, adjuvanted and high-dose influenza vaccines showed no significant ...

Opinion: The Trump administration’s recent censorship of vaccine research sets a dangerous precedent, writes A.J. Russo.

Sources said the wide-ranging inquiry is a top priority for Kennedy, who sees vaccines as a “potential culprit” in various ...

Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government ...

The recombinant zoster vaccine (Shingrix) is very effective against the viral rash, but research has found that it may also ...

Amid apparent overtures from the Trump administration to curb public vaccine criticism ahead of the midterms this fall, the ...

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising ...

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other ...

Covid-19 vaccines roughly halved the chances that a US adult would need to visit the emergency room or be hospitalized with their infections last fall and winter, according to two sources familiar ...

A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...

Researchers are working on a solution that could make vaccines easier to store and transport.